BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11456132)

  • 1. Extremely high drug-reductase activity based on aldehyde oxidase in monkey liver.
    Kitamura S; Ohashi KNK ; Sugihara K; Hosokawa R; Akagawa Y; Ohta S
    Biol Pharm Bull; 2001 Jul; 24(7):856-9. PubMed ID: 11456132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
    Sugihara K; Kitamura S; Tatsumi K
    Drug Metab Dispos; 1996 Feb; 24(2):199-202. PubMed ID: 8742231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cynomolgus monkey liver aldehyde oxidase: extremely high oxidase activity and an attempt at purification.
    Sugihara K; Katsuma Y; Kitamura S; Ohta S; Fujitani M; Shintani H
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 May; 126(1):53-60. PubMed ID: 11048665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxide reductase activity of mammalian liver cytosols and aldehyde oxidase.
    Hirao Y; Kitamura S; Tatsumi K
    Carcinogenesis; 1994 Apr; 15(4):739-43. PubMed ID: 8149489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of tertiary amine N-oxides by liver preparations: function of aldehyde oxidase as a major N-oxide reductase.
    Kitamura S; Tatsumi K
    Biochem Biophys Res Commun; 1984 Jun; 121(3):749-54. PubMed ID: 6743317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide.
    Kitamura S; Tatsumi K
    Biochem Biophys Res Commun; 1984 Apr; 120(2):602-6. PubMed ID: 6233971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of liver aldehyde oxidase in conversion of N-hydroxyurethane to urethane.
    Sugihara K; Kitamura S; Tatsumi K
    J Pharmacobiodyn; 1983 Sep; 6(9):677-83. PubMed ID: 6689178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of drugs in the eye. Drug-reducing activity of preparations from bovine ciliary body.
    Shimada S; Mishima H; Kitamura S; Tatsumi K
    Curr Eye Res; 1988 Nov; 7(11):1069-75. PubMed ID: 3243082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of liver aldehyde oxidase in reductive metabolism of hydroxamic acids to amides.
    Sugihara K; Tatsumi K
    Arch Biochem Biophys; 1986 Jun; 247(2):289-93. PubMed ID: 3717945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mammalian intestinal bacteria in the reductive metabolism of zonisamide.
    Kitamura S; Sugihara K; Kuwasako M; Tatsumi K
    J Pharm Pharmacol; 1997 Mar; 49(3):253-6. PubMed ID: 9231340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfoxide reductase activity of liver aldehyde oxidase.
    Tatsumi K; Kitamura S; Yamada H
    Biochim Biophys Acta; 1983 Sep; 747(1-2):86-92. PubMed ID: 6688361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-(-)-nicotine-1'-N-oxide reductase activity of rat liver aldehyde oxidase.
    Sugihara K; Kitamura S; Tatsumi K
    Biochem Mol Biol Int; 1996 Oct; 40(3):535-41. PubMed ID: 8908363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guinea pig liver aldehyde oxidase as a sulfoxide reductase: its purification and characterization.
    Yoshihara S; Tatsumi K
    Arch Biochem Biophys; 1985 Oct; 242(1):213-24. PubMed ID: 4051501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.
    Austin NE; Baldwin SJ; Cutler L; Deeks N; Kelly PJ; Nash M; Shardlow CE; Stemp G; Thewlis K; Ayrton A; Jeffrey P
    Xenobiotica; 2001; 31(8-9):677-86. PubMed ID: 11569533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic and non-enzymatic reduction of brucine N-oxide by aldehyde oxidase and catalase.
    Takekawa K; Sugihara K; Kitamura S; Ohta S
    Xenobiotica; 2001 Nov; 31(11):769-82. PubMed ID: 11765140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver.
    Rashidi MR; Smith JA; Clarke SE; Beedham C
    Drug Metab Dispos; 1997 Jul; 25(7):805-13. PubMed ID: 9224775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and some properties of hamster liver aldehyde oxidase.
    Sugihara K; Katsuma Y; Tanaka C; Kitamura S
    Biol Pharm Bull; 1999 Nov; 22(11):1246-8. PubMed ID: 10598038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromate reduction by rabbit liver aldehyde oxidase.
    Banks RB; Cooke RT
    Biochem Biophys Res Commun; 1986 May; 137(1):8-14. PubMed ID: 2941018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD (P) H-dependent reduction of nicotinamide N-oxide by an unique enzyme system consisting of liver microsomal NADPH-cytochrome C reductase and cytosolic aldehyde oxidase.
    Kitamura S; Wada Y; Tatsumi K
    Biochem Biophys Res Commun; 1984 Dec; 125(3):1117-22. PubMed ID: 6240269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations.
    Tatsumi K; Kitamura S; Narai N
    Cancer Res; 1986 Mar; 46(3):1089-93. PubMed ID: 3943085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.